ABVC BIOPHARMA, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2019 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Abvc Biopharma, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q1 2024.
- Abvc Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $0.000.
- Abvc Biopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $903K, a 61.5% decline year-over-year.
- Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $451K, a 50% decline from 2023.
- Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $903K, a 87.2% decline from 2022.
- Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.04M, a 32.6% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)